Catalyst Wire Dossier Catalyst Wire Dossier

Oxytocin (GR121619) inhaled

oxytocin · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Oxytocin (GR121619) inhaled, covering 2017-10-19 to 2017-10-19. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Pharmacokinetics (PK) Study of Oxytocin (GR121619) Administered Via an Inhaled Route in Healthy Female Volunteers [Phase 1]

See pricing